| Morphological, cellular, and molecular basis of brain infection in COVID-19 patients F Crunfli, VC Carregari, FP Veras, LS Silva, MH Nogueira, ASLM Antunes, ... Proceedings of the National Academy of Sciences 119 (35), e2200960119, 2022 | 160 | 2022 |
| The energy metabolism dysfunction in psychiatric disorders postmortem brains: focus on proteomic evidence GS Zuccoli, VM Saia-Cereda, JM Nascimento, D Martins-de-Souza Frontiers in neuroscience 11, 277593, 2017 | 122 | 2017 |
| SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability F Crunfli, VC Carregari, FP Veras, PH Vendramini, AGF Valença, ... MedRxiv, 2020.10. 09.20207464, 2021 | 91 | 2021 |
| Proteomics and molecular tools for unveiling missing links in the biochemical understanding of schizophrenia JM Nascimento, S Garcia, VM Saia‐Cereda, AG Santana, ... PROTEOMICS–Clinical Applications 10 (12), 1148-1158, 2016 | 18 | 2016 |
| Digging deeper in the proteome of different regions from schizophrenia brains G Reis-de-Oliveira, GS Zuccoli, M Fioramonte, A Schimitt, P Falkai, ... Journal of proteomics 223, 103814, 2020 | 15 | 2020 |
| Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms V Mendes de Almeida, DF Engel, MF Ricci, CS Cruz, ÍS Lopes, DA Alves, ... Gut Microbes 15 (2), 2249146, 2023 | 12 | 2023 |
| Gut microbiota from patients with mild COVID-19 cause alterations in mice that resemble post-COVID syndrome VM de Almeida, DF Engel, MF Ricci, CS Cruz, IS Lopes, DA Alves, ... Research Square, 2022 | 11 | 2022 |
| Combining patient-reprogrammed neural cells and proteomics as a model to study psychiatric disorders GS Zuccoli, D Martins-de-Souza, PC Guest, SK Rehen, JM Nascimento Proteomic Methods in Neuropsychiatric Research, 279-287, 2017 | 11 | 2017 |
| Effects on glial cell glycolysis in schizophrenia: an advanced aging phenotype? GS Zuccoli, PC Guest, D Martins-de-Souza Reviews on Biomarker Studies in Aging and Anti-aging Research, 25-38, 2019 | 10 | 2019 |
| Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains JM Nascimento, VM Saia-Cereda, GS Zuccoli, G Reis-de-Oliveira, ... Cell & bioscience 12 (1), 189, 2022 | 9 | 2022 |
| Synapse preservation and decreased glial reactions following ventral root crush (VRC) and treatment with 4‐hydroxy‐tempo (TEMPOL) AB Spejo, CB Teles, GS Zuccoli, ALR Oliveira Journal of neuroscience research 97 (4), 520-534, 2019 | 9 | 2019 |
| Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia GS Zuccoli, JM Nascimento, PM Moraes-Vieira, SK Rehen, ... European Archives of Psychiatry and Clinical Neuroscience 273 (8), 1649-1664, 2023 | 8 | 2023 |
| SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. medRxiv 2021 F Crunfli, VC Carregari, FP Veras, PH Vendramini, AG Valença, ... Google Scholar, 0 | 8 | |
| Exogenous succinate impacts mouse brown adipose tissue mitochondrial proteome and potentiates body mass reduction induced by liraglutide RS Gaspar, J Delafiori, G Zuccoli, VC Carregari, TP Prado, J Morari, ... American Journal of Physiology-Endocrinology and Metabolism 324 (3), E226-E240, 2023 | 7 | 2023 |
| Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes GS Zuccoli, G Reis-de-Oliveira, B Garbes, P Falkai, A Schmitt, HI Nakaya, ... European archives of psychiatry and clinical neuroscience 271, 1579-1586, 2021 | 6 | 2021 |
| Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes V de Almeida, G Seabra, G Reis-de-Oliveira, GS Zuccoli, P Rumin, ... European Archives of Psychiatry and Clinical Neuroscience 272 (7), 1311-1323, 2022 | 3 | 2022 |
| Zika virus strains and dengue virus induce distinct proteomic changes in neural stem cells and neurospheres JM Nascimento, D Gouvêa-Junqueira, GS Zuccoli, CSG Pedrosa, ... Molecular neurobiology 59 (9), 5549-5563, 2022 | 3 | 2022 |
| Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat Schizophrenia GS Zuccoli, C Brandão-Teles, GM Vieira, FV Gomes, F Crunfli Neuroproteomics as a Tool for Understanding Schizophrenia, 89-103, 2022 | 3 | 2022 |
| Protein succinylation and malonylation as potential biomarkers in schizophrenia BJ Smith, C Brandão-Teles, GS Zuccoli, G Reis-de-Oliveira, M Fioramonte, ... Journal of personalized medicine 12 (9), 1408, 2022 | 2 | 2022 |
| Mitochondrial Dysregulation and the Influence in Neurodegenerative Diseases GS Zuccoli, VC Carregari Understanding PTMs in Neurodegenerative Diseases, 109-118, 2022 | 1 | 2022 |
